Telix Doses First Patient in European TLX250-CDx Trial miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a named patient (early.
New research has found that it is safe for people who take statins to engage in moderate-intensity exercise. The findings are valid both for those with and without muscle problems.